Subscribe to Newsletter
Diagnostics Genetics and epigenetics

Genetic and Transcriptional Contributions to Relapse in Acute Myeloid Leukemia

sponsored by 10x Genomics

Available On-Demand

For patients with acute myeloid leukemia (AML) treated with chemotherapy, the contribution of genetic heterogeneity to drug resistance and disease progression has been well-established. More recently, studies have begun to investigate the impact of transcriptional heterogeneity to tumor adaptability. However, bulk RNA-sequencing has lacked the resolution to allow the identification of canonical, relapse-associated transcriptional changes. To better understand relapse-associated clonal and transcriptional adaptation, Dr. Allegra Petti and colleagues turned to enhanced whole genome sequencing (eWGS) and ultra-deep single cell RNA-sequencing (scRNA-seq) to examine the correlation between genetic and transcriptional evolution. 

Join this webinar, to hear Dr. Petti discuss the findings of this study and learn about:

  • How integration of eWGS and scRNA-seq enabled quantitative measurement of the co-evolution of genetic and transcriptional heterogeneity and resolved subclone-specific states
  • Findings indicating that clonal evolution does not represent all relevant biological changes
  • The identification of leukemic cells seeding resistance

Available On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Evaluation of cell-free fetal DNA to determine fetal RhD status

| Contributed by Revvity

Preventing Bias in scRNAseq Performed on Solid Tumors

| Contributed by Revvity

Enabling Efficient, Cost-effective Sequencing of the Human Whole Exome

| Contributed by Revvity

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine